Menstrual cycle-dependent alterations in glycosylation: a roadmap for defining biomarkers of favorable and unfavorable mucus
- 9 May 2019
- journal article
- research article
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 36 (5) , 847-855
Abstract
Objective To understand glycosylation of endocervical proteins at different times throughout the menstrual cycle in naturally cycling women and in women using hormonal or non-hormonal contraceptive methods, in order to characterize biochemical fingerprints of favorable and unfavorable cervical mucus. Design Lectin/antibody-probed protein blot analysis of endocervical mucus samples collected onto ophthalmologic sponges (wicks) from two groups: a longitudinal cohort of naturally cycling women at three time points in their menstrual cycles (discovery cohort), and a cross-sectional cohort of women on hormonal or non-hormonal contraceptive methods (validation cohort). Setting Participants were recruited from the San Francisco Bay Area from 2010 to 2016. Patient(s) Women with regular cycles not using hormonal or intrauterine device (IUD) contraceptives were recruited for the longitudinal cohort (n = 8). Samples from women using levonorgestrel-containing combined oral contraceptives (n = 16), levonorgestrel containing IUDs (n = 14), copper IUDs (n = 17), depo-medroxyprogesterone acetate (DMPA) (n = 15), and controls (n = 13) were used for validation. Intervention(s) None. Main outcome measure(s) Detection of specific glycosylation patterns on lectin/antibody probed protein blots. Result(s) Two lectins (Lens culinaris agglutinin and Lycopersicon esculentum [tomato lectin]), and the antibody MECA-79 demonstrated consistent cycle-dependent changes in protein binding. The glycan-binding patterns of the levonorgestrel-containing contraceptives were generally similar to each other and to those from women in the luteal phase. The DMPA samples showed slightly different binding patterns. Conclusion(s) We identified molecular signatures of unfavorable mucus from women in the luteal phase and on hormonal contraceptives. Further characterization of these biomarkers may be useful in contraceptive development and in evaluation of infertility.Keywords
Funding Information
- National Institutes of Health (R01 AI111925, P01 AI083050)
This publication has 16 references indexed in Scilit:
- Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover StudyPLOS ONE, 2015
- History of Plant Lectin Research2014
- Statistical Design for Biospecimen Cohort Size in Proteomics-based Biomarker Discovery and Verification StudiesJournal of Proteome Research, 2013
- Contraceptive methods women have ever used: United States, 1982-2010.2013
- Cervical mucus from biochemical structure to clinical implicationsFrontiers in Bioscience-Scholar, 2013
- Large Scale Identification of Proteins, Mucins, and Their O-Glycosylation in the Endocervical Mucus during the Menstrual CycleMolecular & Cellular Proteomics, 2007
- Trophoblast L-Selectin-Mediated Adhesion at the Maternal-Fetal InterfaceScience, 2003
- Mucins of the human endocervixFrontiers in Bioscience-Landmark, 2001
- Optimization of the Weck-Cel Collection Method for Quantitation of Cytokines in Mucosal SecretionsClinical and Diagnostic Laboratory Immunology, 2000
- The mechanism of action of hormonal contraceptives and intrauterine contraceptive devicesAmerican Journal of Obstetrics and Gynecology, 1999